Opportunity with Neoplasia journal – Commissioning Editor Oncology (call for applications)
8 Dec 2021
As a partner to ScienceDirect through the European Journal of Cancer (EORTC’s Official Journal), we are pleased to herewith share an exciting opportunity with one of the publisher’s other journals, Neoplasia.
Neoplasia – a peer-reviewed journal of the ScienceDirect family that publishes the results of novel investigations in all areas of oncology research – is currently recruiting for a Commissioning Editor in Oncology.
The role of the Commissioning Editor Oncology will be to attract key individuals as top authors to the journal.
Candidates for the role should have a scientific background in Cancer Research / Oncology (PhD minimum), a good understanding of related & interdisciplinary areas with a view of emerging topics, international connections within/across the scientific community, as well as strong networking capabilities and an interest in scientific publishing.
Deadline for applications is December 18, 2021.
For more information on expectations of the role and details of the application process, read on here.
Related News
First site activated in EORTC STARBURST-1, the research project on muscle-invasive bladder cancer
28 Oct 2026
EORTC at ESMO 2026: New findings and ongoing studies
27 Oct 2026
EORTC research presented at ESMO 2026
22 Oct 2026
EORTC Quality of Life Group at ISOQOL 2026
15 Oct 2026
Pink October 2026: Advancing breast cancer research, together
7 Oct 2026
EORTC presents new results in neuro-oncology at EANO
28 Sep 2026
In Memoriam: Neil Aaronson, founding member of the EORTC Quality of Life Group
7 Sep 2026
New EORTC perspective calls for patient preferences to become a standard part of cancer trials for older adults
4 Sep 2026
New EORTC questionnaire sets a global standard for measuring quality of life in cancer survivors
25 Aug 2026
EORTC calls for a balanced and feasible European Health Data Space (EHDS)
8 Jul 2026
